• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定原料药及药物剂型中硫酸头孢匹罗的新型稳定性指示反相高效液相色谱法

New Stability Indicating RP-HPLC Method for the Estimation of Cefpirome Sulphate in Bulk and Pharmaceutical Dosage Forms.

作者信息

Rao Kareti Srinivasa, Kumar Keshar Nargesh, Joydeep Datta

机构信息

Roland Institute of Pharmaceutical Sciences, Berhampur, Orissa-760 010, India.

出版信息

Sci Pharm. 2011 Oct-Dec;79(4):899-907. doi: 10.3797/scipharm.1104-25. Epub 2011 Aug 7.

DOI:10.3797/scipharm.1104-25
PMID:22145113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3221494/
Abstract

A simple stability indicating reversed-phase HPLC method was developed and subsequently validated for estimation of Cefpirome sulphate (CPS) present in pharmaceutical dosage forms. The proposed RP-HPLC method utilizes a LiChroCART-Lichrosphere100, C18 RP column (250 mm × 4mm × 5 μm) in an isocratic separation mode with mobile phase consisting of methanol and water in the proportion of 50:50 % (v/v), at a flow rate 1ml/min, and the effluent was monitored at 270 nm. The retention time of CPS was 2.733 min and its formulation was exposed to acidic, alkaline, photolytic, thermal and oxidative stress conditions, and the stressed samples were analyzed by the proposed method. The described method was linear over a range of 0.5-200μg/ml. The percentage recovery was 99.46. F-test and t-test at 95% confidence level were used to check the intermediate precision data obtained under different experimental setups; the calculated value was found to be less than the critical value.

摘要

开发了一种简单的稳定性指示反相高效液相色谱法,并随后对其进行验证,以测定药物剂型中存在的硫酸头孢匹罗(CPS)。所提出的反相高效液相色谱法采用LiChroCART-Lichrosphere100、C18反相柱(250 mm×4mm×5μm),在等度分离模式下,流动相由甲醇和水按50:50%(v/v)的比例组成,流速为1ml/min,流出物在270nm处进行监测。CPS的保留时间为2.733分钟,其制剂暴露于酸性、碱性、光解、热和氧化应激条件下,并用所提出的方法对应激样品进行分析。所述方法在0.5-200μg/ml范围内呈线性。回收率为99.46%。使用95%置信水平的F检验和t检验来检查在不同实验设置下获得的中间精密度数据;发现计算值小于临界值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d22/3221494/af7f78a18cf3/scipharm-2011-79-899f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d22/3221494/835b0f58c140/scipharm-2011-79-899f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d22/3221494/af7f78a18cf3/scipharm-2011-79-899f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d22/3221494/835b0f58c140/scipharm-2011-79-899f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d22/3221494/af7f78a18cf3/scipharm-2011-79-899f2.jpg

相似文献

1
New Stability Indicating RP-HPLC Method for the Estimation of Cefpirome Sulphate in Bulk and Pharmaceutical Dosage Forms.用于测定原料药及药物剂型中硫酸头孢匹罗的新型稳定性指示反相高效液相色谱法
Sci Pharm. 2011 Oct-Dec;79(4):899-907. doi: 10.3797/scipharm.1104-25. Epub 2011 Aug 7.
2
Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Doxofylline and Terbutalinesulphate in Pharmaceutical Formulations.用于同时测定药物制剂中多索茶碱和硫酸特布他林的稳定性指示反相高效液相色谱法
Sci Pharm. 2013 Jul 14;81(4):969-82. doi: 10.3797/scipharm.1305-14. Print 2013 Oct-Dec.
3
Development and validation of a stability-indicating RP-HPLC method for estimation of atazanavir sulfate in bulk.用于原料药硫酸阿扎那韦含量测定的稳定性指示反相高效液相色谱法的建立与验证
J Pharm Anal. 2017 Apr;7(2):134-140. doi: 10.1016/j.jpha.2013.12.002. Epub 2013 Dec 31.
4
Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of simvastatin and ezetimibe from their combination drug products.用于同时测定辛伐他汀和依折麦布复方制剂中这两种成分的稳定性指示反相液相色谱法。
J AOAC Int. 2007 Sep-Oct;90(5):1242-9.
5
Validation of assay indicating method development of meloxicam in bulk and some of its tablet dosage forms by RP-HPLC.采用反相高效液相色谱法对美洛昔康原料药及其部分片剂剂型进行含量测定方法开发的方法验证。
Springerplus. 2014 Feb 18;3:95. doi: 10.1186/2193-1801-3-95. eCollection 2014.
6
Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product.用于同时测定复方制剂中氨氯地平和盐酸贝那普利的稳定性指示反相高效液相色谱法。
J Pharm Biomed Anal. 2005 Sep 1;39(1-2):147-55. doi: 10.1016/j.jpba.2005.04.001.
7
Stability Indicating Assay Method for the Quantitative Determination of Olaparib in Bulk and Pharmaceutical Dosage Form.用于定量测定原料药和制剂中奥拉帕利的稳定性指示分析方法。
Turk J Pharm Sci. 2022 Oct 31;19(5):488-497. doi: 10.4274/tjps.galenos.2021.48861.
8
Development and validation of stability-indicating HPLC method for determination of cefpirome sulfate.用于测定硫酸头孢匹罗的稳定性指示高效液相色谱法的建立与验证
Acta Pol Pharm. 2014 Sep-Oct;71(5):731-6.
9
Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products.用于同时测定阿托伐他汀和依折麦布复方制剂中两者含量的稳定性指示反相液相色谱法。
J AOAC Int. 2007 Nov-Dec;90(6):1539-46.
10
Development and Validation of an RP-HPLC Method for Quantitative Estimation of Eslicarbazepine Acetate in Bulk Drug and Tablets.一种用于定量测定原料药和片剂中醋酸艾司利卡西平的反相高效液相色谱法的开发与验证
Indian J Pharm Sci. 2013 Nov;75(6):736-9.

本文引用的文献

1
Development of an analytical method for cefpirome in plasma by simplified HPLC technique and its applications.用简化高效液相色谱技术测定血浆中头孢匹罗的分析方法的建立及其应用
Arzneimittelforschung. 2010;60(6):336-9. doi: 10.1055/s-0031-1296297.
2
A rp-HPLC method for the assay of cefpirome and its application in drug-metal interaction studies.
Pak J Pharm Sci. 2006 Jan;19(1):39-44.
3
Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction.
J Chromatogr B Biomed Sci Appl. 1999 Oct 29;734(1):121-7. doi: 10.1016/s0378-4347(99)00343-6.
4
A rapid high-performance liquid chromatographic assay for cefepime, cefpirome and meropenem.
J Antimicrob Chemother. 1998 Jul;42(1):121-3.
5
In vitro activity of HR 810, a new cephalosporin.新型头孢菌素HR 810的体外活性
Antimicrob Agents Chemother. 1984 Aug;26(2):277-9. doi: 10.1128/AAC.26.2.277.
6
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.临床微生物实验室中第四代头孢菌素HR810的纸片扩散法检测、质量控制指南及抗菌谱
J Clin Microbiol. 1984 Sep;20(3):409-12. doi: 10.1128/jcm.20.3.409-412.1984.
7
The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.新型头孢菌素HR 810与其他五种头孢菌素及两种氨基糖苷类药物相比的体外抗菌活性及β-内酰胺酶稳定性
Infection. 1983 Sep-Oct;11(5):275-9. doi: 10.1007/BF01641262.
8
Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivative.
Infection. 1987 May-Jun;15(3):211-4. doi: 10.1007/BF01646053.
9
Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate.
Infection. 1987 May-Jun;15(3):202-6. doi: 10.1007/BF01646051.
10
Determination of cefpirome (HR 810) in serum and urine.
Infection. 1988 Mar-Apr;16(2):135-40. doi: 10.1007/BF01644323.